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ABSTRACT
Deposition of replication-independent histone vari-
ant H3.3 into chromatin is essential for many biologi-
cal processes, including development and reproduc-
tion. Unlike replication-dependent H3.1/2 isoforms,
H3.3 is expressed throughout the cell cycle and be-
comes enriched in postmitotic cells with age. How-
ever, lifelong dynamics of H3 variant replacement
and the impact of this process on chromatin orga-
nization remain largely undefined. Using quantita-
tive middle-down proteomics we demonstrate that
H3.3 accumulates to near saturation levels in the
chromatin of various mouse somatic tissues by late
adulthood. Accumulation of H3.3 is associated with
profound changes in global levels of both individual
and combinatorial H3 methyl modifications. A subset
of these modifications exhibit distinct relative abun-
dances on H3 variants and remain stably enriched on
H3.3 throughout the lifespan, suggesting a causal re-
lationship between H3 variant replacement and age-
dependent changes in H3 methylation. Furthermore,
the H3.3 level is drastically reduced in human hepato-
carcinoma cells as compared to nontumoral hepato-
cytes, suggesting the potential utility of the H3.3 rel-
ative abundance as a biomarker of abnormal cell pro-
liferation activity. Overall, our study provides the first
quantitative characterization of dynamic changes in
H3 proteoforms throughout lifespan in mammals and
suggests a role for H3 variant replacement in modu-
lating H3 methylation landscape with age.
INTRODUCTION
Chromatin is a highly complex and dynamic nucleopro-
tein structure that controls all DNA-templated processes
by modulating the accessibility of DNA to nuclear factors,
such as transcription and DNA repair machineries. Dy-
namic changes in chromatin organization are central for
regulating transcriptional programs during development
and in response to internal and external stimuli. Dysregula-
tion of chromatin-associated pathways may lead to various
pathological conditions such as developmental abnormali-
ties, cancer and age-related diseases (1–3).
Regulation of chromatin architecture and function is
largely accomplished by post-translational modifications
(PTMs) of histone proteins (4,5). Over 20 distinct types of
histone PTMs have been described (6), among which the
most abundant ones are acetylation and methylation of ly-
sine residues (7). Histone PTMs can be deposited on and
removed from chromatin by different enzymes, known as
histone PTM ‘writers’ and ‘erasers’ (8). Histone PTMs ex-
ert their regulatory effects via two main mechanisms. First,
histone PTMs serve as docking sites for various nuclear
proteins––histone PTM ‘readers’––that specifically recog-
nize modified histone residues through their modification-
binding domains (9). Recruitment of these proteins at
specific genomic loci promotes key chromatin processes,
such as transcriptional regulation and DNA damage repair
(10,11). Second, some histone PTMs, such as acetylation,
directly affect chromatin higher-order structure and com-
paction (12), thereby controlling chromatin accessibility to
protein machineries such as those involved in transcription
(13). Chromatin states defined by histones PTMs can be
transmitted through cell divisions and are thought to play
a role in the inheritance of specific gene expression profiles
(14–16).
Another level of chromatin regulation is accomplished
by a dynamic exchange of canonical histones with specific
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histone variants (17). Histone variants are non-allelic iso-
forms of canonical histones that differ in their primary
sequence and functional properties. Unlike canonical his-
tones that are expressed and incorporated into chromatin
preferentially, although not exclusively (18,19), during the
S phase in DNA synthesis-coupled (DSC) manner, his-
tone variants are expressed throughout the cell cycle and
replace their canonical counterparts via DNA synthesis-
independent (DSI) nucleosome assembly pathways (20).
Substitution of canonical histones with histone variants
can influence the structural properties of the nucleosome,
thereby affecting different chromatin processes (21). In par-
ticular, the evolutionarily conserved histone variant H3.3
was recently implicated in transcriptional regulation, retro-
transposon silencing and maintenance of genome integrity
(22–25). In metazoans, H3.3 differs from canonical H3 iso-
forms, i.e. H3.2 and H3.1, by only four and five amino
acid residues, respectively. These amino acid substitutions
inH3.3mediate its specific interaction with chaperone com-
plexesHIRAandATRX/DAXXwhich depositH3.3 at dis-
tinct chromatin regions, including gene bodies, telomeres
and pericentric chromatin (26–28). Depletion of H3.3 as
well as a disruption of H3.3 nucleosome assembly pathways
results in early embryonic lethality in mice and impairs late
gastrulation in Xenopus (22,29).
A growing body of evidence indicates that H3.3 plays
an essential role in maintaining and regulating chromatin
organization in postmitotic cells. In oocytes, DSI deposi-
tion of H3.3 into the chromatin is required for efficient de
novo DNA methylation and transcriptional transitions as-
sociated with oocyte maturation (30). H3.3 controls gene
expression programs and plasticity in mammalian neurons,
where it progressively accumulates and replaces canonical
H3.1/2 isoforms with age (31). H3.3 accumulation was also
observed in non-proliferating chicken tissues and senescent
human fibroblasts (32,33). In line with these findings, the
progressive replacement of H3.1/2 by the H3.3 was hypoth-
esized to constitute a common feature of chromatin organi-
zation in postmitotic cells (34). This hypothesis is partic-
ularly intriguing in light of emerging evidence indicating
that H3.3 is functionally distinct from its canonical coun-
terparts (35,36). In particular, recent studies have demon-
strated that the conserved amino acid variations between
canonical H3.1/2 isoforms andH3.3 variant can directly af-
fect the deposition and functional readout of PTMs of these
proteins (35,37,38). However, lifelong dynamics of H3 vari-
ant replacement in mammals and the effect of this process
on theH3modification landscape remain largely undefined.
Here, we provide quantitative mass spectrometry (MS)-
based middle-down proteomic characterization of dynamic
changes in histoneH3 proteoforms at five time points across
the lifespan in mice, covering ages 3–24 months.We demon-
strate that the histone variant H3.3 progressively accumu-
lates in various mouse somatic tissues with age, resulting
in near complete replacement of the canonical H3.1/2 iso-
forms by the age of 18months.H3 variant replacement is as-
sociated with profound changes in global levels of a number
of individual and combinatorial H3 methyl PTMs, among
which some PTMs, such as K36me2 and K27me2K36me2,
exhibit stable lifelong enrichment on H3.3. Bioinformatic
analysis of 128 quantitative MS datasets obtained in this
study reveals several unexpected features of H3 modifica-
tion landscape organization, including the strong corre-
lation between global levels of H3 methylation at lysines
9(K9), 27(K27) and 36(K36). Finally, we show that H3.3
accumulation profile is not restricted to mouse cells, but
is also observed in non-tumor adult human hepatocytes,
while the chromatin of hepatocarcinoma cells is preferen-
tially marked by the H3.1/2. All proteomicMS datasets ob-
tained in the study were deposited into the PRIDE database
(dataset identifier PXD005300) and the CrosstalkDB re-
source (http://crosstalkdb.bmb.sdu.dk/).
MATERIALS AND METHODS
Animals and tissue collection
Male C57BL/6J mice were obtained from a study approved
by the Danish Animal Ethics Inspectorate (J. no. 2011/561-
1950). Wild-type mice were bred in the Biomedical Labo-
ratory, University of Southern Denmark under a 12 h:12
h light:dark cycle (lights on at 6:30 a.m.). Food and wa-
ter were available ad libitum. Mice were sacrificed by cer-
vical dislocation at ages of 3, 5, 10, 18 and 24 months.
Liver, kidney, brain and heart were excised, rinsed in ice-
cold phosphate-buffered saline (PBS) andwere immediately
snap-frozen. Tissues were stored at –80◦C until further pro-
cessing.
Primary human hepatocytes
Primary adult human hepatocytes were purchased from
BioreclamationIVT (Brussels, Belgium).
Human tissue samples
Protein lysates of human hepatocarcinoma tissues and
matched normal liver tissues were purchased from Acris
Antibodies GmbH and from Origene Inc.
Sample preparation for proteomic analysis
Mouse tissues were homogenized on ice in nuclei isolation
buffer (NIB; 15 mM Tris–HCl (pH 7.5), 60 mM KCl, 11
mM CaCl2, 5 mM NaCl, 5 mM MgCl2, 250 mM sucrose,
1 mM dithiothreitol, 10 mM sodium butyrate and 0.3%
NP-40) supplementedwith protease (Complete;Roche) and
phosphatase inhibitors (PhosSTOP, Roche) using a pestle
tissue grinder (Wheaton Science Products). Nuclei were pel-
leted by centrifugation (1200 × g for 10 min) and washed
twice with ice-cold NIB (without NP-40). Histones were
acid extracted from the resulting nuclei pellet as previously
described (39).
Immunoblot analysis
Immunoblot analysis was performed as described pre-
viously (40). The following antibodies were used: anti-
H3.3 (1:1000; ab176840, Abcam) or anti-H3 (1:5000;
ab1791, Abcam) primary antibodies, followed by sec-
ondary horseradish peroxidase (HRP)-conjugated antibod-
ies (1:5000; ab6721, Abcam).
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Middle-down mass spectrometry analysis
Acid-precipitated bulk histones were resuspended in 100
mM NH4HCO3 (pH 4) to a final protein concentra-
tion of ∼1 mg/ml and subjected to endoproteinase GluC
digestion (Calbiochem, 1:10 enzyme to substrate ra-
tio) performed for 6 h at room temperature. The re-
sulting peptide mixtures were analyzed by the on-line
nanoflow weak cation exchange–hydrophilic interaction
liquid chromatography–tandem mass spectrometry (WCX-
HILIC-MS/MS) method adapted from our previous stud-
ies (41,42). About 4 g of peptide mixture were separated
using Dionex Ultimate 3000 high-performance liquid chro-
matography (HPLC) system (Thermo Scientific) equipped
with a two-column setup, consisting of a reversed-phase
trap column (3 cm, 100 m i.d., 360 m o.d., packed with
ReproSil, Pur C18AQ 3 m; Dr Maisch) and a WCX-
HILIC analytical column (15 cm, 75 m i.d. 360 m o.d.,
packed with PolycatA 1000 A˚, 1.9 m, PolyLC Inc). Load-
ing buffer was 0.1% formic acid (MerckMillipore) in water.
Buffer A and B were prepared as described (43). Peptides
were eluted directly into an ESI tandem mass spectrometer
(Orbitrap Fusion ETD, Thermo Fisher Scientific) using a
130-min linear gradient of 65–85% buffer B at a flow rate
of 230 nl/min. The MS instrument was controlled by Xcal-
ibur software (Thermo Fisher Scientific). The nanoelectro-
spray ion source (Thermo Fisher Scientific) was used with
a spray voltage of 2.2 kV. The ion transfer tube temperature
was 275◦C. Data acquisition was performed in the Orbitrap
for both precursor ions and product ions. MS survey scans
were obtained for the m/z range of 400–750 in the Orbitrap
with maximum ion injection time of 50 ms, auto gain con-
trol target 5 × 105, mass resolution of 60 000 and three mi-
croscans per each full MS event. The four most intense ions
withMS1 signal higher than 20 000 counts were selected for
fragmentation using electron transfer dissociation (ETD).
In order to fragment only histone H3 N-terminal peptide
proteoforms the following criteria for the precursor ion se-
lection were applied: m/z range of 667–703 and charge +8;
m/z range of 593–625 and charge +9; m/z range of 533–
562 and charge +10;m/z range of 485–512 and charge +11.
MS/MS spectra were measured in the Orbitrap with max-
imum ion injection time 100 ms, auto gain control target 2
× 105, mass resolution of 30 000 and three microscans per
MS/MS.
Middle-down MS data processing and analysis
Database search. Raw MS files were processed and
searched with Mascot (version 2.3.2, Matrix Science, Lon-
don, UK) using the Proteome Discoverer (version 1.4,
Thermo Fischer Scientific) data analysis package. Spectra
were deconvoluted using the Xtract tool (Thermo Fisher
Scientific) with the following parameters: S/N threshold
was set to 1, mass resolution at 400 m/z was 30 000. The
following parameters were used in the Mascot search: MS
mass tolerance: 1.05 Da, to include possible errors in iso-
topic recognition; MS/MS mass tolerance: 0.02 Da; en-
zyme: GluC with no missed cleavage allowed; mono- and
dimethylation (KR), trimethylation (K) and acetylation (K)
were set as variable modifications. MS/MS spectra were
searched against mouse histone database consisting of hi-
stone H3.1/H3.2 and H3.3 N-terminal sequences covering
amino acid (aa) residues 1–50.
Validation of PTM site assignments. Database search re-
sult files from Mascot were exported into CSV file format
and processed by isoScale slim (http://middle-down.github.
io/Software, (41)) with a mass tolerance of 0.015 Da and
only c/z fragment ions allowed. Only PTMs with at least
one site determining ion before and after the assigned PTM
site were accepted.
Peptide quantification. H3 N-terminal peptides were
quantified based on the total ion current of their MS/MS
spectra (MS2-TIC) using the isoScale slim software. In
a case of mixed MS/MS spectra generated as a result
of co-fragmentation of co-selected isobaric peptides, i.e.
peptides which share the same sequence and have the same
masses but have distinct localizations of PTMs, isoScale
slim calculated the fragment ion relative ratio (FIRR) (44)
of such peptides and divided the MS2-TIC for this ratio.
Relative quantification of single and combinatorial H3
PTMs. The relative abundance of each unique H3 N-
terminal peptide proteoform, i.e. unmodified or modified
H3.1/2 or H3.3 N-terminal peptide bearing single or com-
binatorial PTM, hereinafter referred to as H3 proteo-
form, was calculated by summingMS2-TIC for all peptide-
spectrum matches (PSMs) corresponding to the given pro-
teoform and dividing the sum intensity by the total inten-
sity of all quantified H3 N-terminal proteoforms. For ex-
ample, the relative abundance ofH3.3K27me2K36me2 pro-
teoform was calculated as the sum of MS2-TICs for all
H3.3K27me2K36me2 PSMs divided by the sum of MS2-
TICs for all H3.1/2 and H3.3 PSMs.
The relative abundance of each single or combinatorial
PTM (for definitions see Table 1) on total H3 (also referred
to as global level) was calculated by summing the relative
abundances of both H3.1/2 and H3.3 proteoforms carry-
ing the given PTM. For example, the relative abundance of
combinatorial PTM H3K27me2K36me2 was calculated as
the sum of relative abundances of H3.1/2K27me2K36me2
and H3.3K27me2K36me2.
The relative abundance of each single or combinatorial
PTM onH3.3 (H3.1) was calculated by normalizing the rel-
ative abundance of H3.3 (H3.1/2) proteoforms carrying the
given PTM by the relative abundance of H3.3 (H3.1/2) cal-
culated as a sum of relative abundances of all H3.3 (H3.1/2)
proteoforms.
Relative quantification of individual H3 PTMs. The rela-
tive abundance of each individual modification (for defi-
nition see Table 1) on total H3 (also referred to as global
level) was calculated as the sum of relative abundances of all
H3 proteoforms containing the given modification. For ex-
ample, the relative abundance of H3K9me2 was calculated
by summing the relative abundances of all H3 proteoforms
containing K9me2 alone or in combination with any other
H3 PTM(s).
The relative abundance of each individual modification
onH3.3 (H3.1/2)was calculated as the sumof relative abun-
dances of all H3.3 (H3.1/2) proteoforms containing the
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Table 1. Definitions for distinct modification types and quantitative MS measurements used in the study
Modification type Meaning Examples
Single PTM Specified aa residue within H3 N-terminal tail
is modified by a given PTM; other aa residues
are unmodified
H3K9me2: H3K9 is dimethylated; other H3
N-terminal tail aa residues are unmodified
Individual PTM Specified aa residue within H3 N-terminal tail
is modified by a given PTM; other aa residues
can either be modified or unmodified
H3K9me2: H3K9 is dimethylated; other H3
N-terminal tail aa residues can either be modified
or unmodified
Combinatorial PTM Specified aa residues within H3 N-terminal tail
are modified by a given PTM(s); other aa
residues are unmodified
H3K9me2K27me3: H3K9 and H3K27 are di- and
trimethylated, respectively; other H3 N-terminal
tail aa residues are unmodified
Binary PTM Two specified aa residues within H3 N-terminal
tail are modified by given a PTM(s); other aa
residues can either be modified or unmodified
H3K9me2K27me3: H3K9 and H3K27 are di- and
trimethylated, respectively; other H3 N-terminal
tail aa residues can either be modified or
unmodified
Quantitative MS measurement Meaning Examples
Relative abundance (RA) of PTM on total H3 Proportion (%) of all H3 N-terminal tails
carrying a given PTM
It is important to distinguish the difference
between the RAs of single and individual PTMs:
RA of PTM on H3.3 (H3.1/2) Proportion (%) of H3.3 (H3.1/2) N-terminal
tails carrying a given PTM
RA of a single PTM H3K9me2 is 1% means that
1% of all H3 N-terminal tails is modified by
K9me2 with NO other modifications present on
them.
RA of an individual PTM H3K9me2 is 1% means
that 1% of all H3 N-terminal tails is modified by
K9me2 alone or in combination with any other H3
PTM(s).
given modification normalized by the relative abundance of
H3.3 (H3.1/2).
Analysis of interplay between histone PTMs
To assess which PTMs tend to attract or repel each other
within H3 N-terminal tail we used the interplay score that
we recently introduced (41,45). This score was calculated as
Ixy = log2(Fxy/FxFy), where Ixy is the interplay score be-
tween the modifications X and Y, Fxy is the co-frequency
and Fx or Fy are the relative abundances of the individual
modifications in the dataset. The co-frequency of the two
modifications X and Y (also referred to as a relative abun-
dance of binary PTM) was calculated by summing the rela-
tive abundances of allH3 proteoforms simultaneously deco-
rated by both modifications. Positive interplay score values
indicate a tendency to co-exist more often than if the two
modifications were completely independent of each other,
while negative values indicate the opposite.
Targeted LC–MS/MS analysis of human tissue lysates
Tumor and non-tumor human liver tissue lysates from pa-
tients 1–4 were separately pooled by equal protein mass.
A 60 g protein aliquot from each pool was run on 4–
12% SDS-PAGE gel followed by staining with Coomassie
Blue. The protein bands corresponding to histone H3 (and
its truncated proteoform (42,46)) were cut out from SDS-
PAGEgels. Histones were in-gel propionylated and digested
according to (47). Resulting peptidemixtures were analyzed
in duplicates using targeted bottom-up LC–MS method
adapted from (48). Relative abundance of H3.3 (H3.1/2)
variant was calculated as the sum of integrated MS1 in-
tensities for all H3.3 (H3.1/2) peptide proteoforms cover-
ing aa residues 27–40, including all differentially modified
H3.3 (H3.1/2) peptides, normalized by the total intensity of
all H3 peptides covering residues 27–40.
Statistical analysis
Tissues derived from 3-, 5- and 10-month-old mice were
analyzed in four biological replicates and tissues derived
from 18- and 24-month-old mice were analyzed in two bi-
ological replicates. Each biological sample was analyzed by
LC-MS/MS in two technical replicates. Differences in H3
PTM abundances between age groups were determined us-
ing the Limma package in R/Bioconductor. Differences in
H3 PTMabundances betweenH3 variants were determined
using paired t-test. All p-values were corrected for multiple
testing using the Benjamini–Hochbergmethod. Statistically
significant differences are indicated by asterisks (P < 0.05
[*], P < 0.01 [**] and P < 0.001 [***]), n.s. indicates non-
significant.
RESULTS
Histone variant H3.3 replaces canonical H3.1/2 isoforms in
mouse somatic tissues with age
Histone variant H3.3 was previously shown to accumu-
late in the mouse brain with age (31,49). We first investi-
gatedwhetherH3.3 also accumulates in othermouse tissues.
To address this, we analyzed the relative abundance of H3
variants in chromatin isolated from liver, kidney, heart and
brain tissues, derived from 3- to 24-month-old C57BL/6J
mice. Immunoblot analysis with histone variant–specific
antibodies demonstrated pronounced enrichment of the
H3.3 in all analyzed tissues harvested from old mice as
compared to those tissues obtained from young mice (Fig-
ure 1A). To quantitatively assess dynamics of H3.1/2 re-
placement by the H3.3 we determined the relative abun-
dances of histone H3 variants in the chromatin at five
time points across mouse lifespan using middle-down MS.
Middle-downMS is based on the analysis of long (≥5 kDa)
N-terminal histone peptides and enables detection, char-
acterization and quantitation of a distinct H3 species, in-
cluding canonical H3.1/2 isoforms andH3.3 variant as well
as their differentially modified proteoforms bearing single
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Figure 1. Histone H3.3 accumulates and replaces canonical H3 isoforms with age. (A) Immunoblot analysis of H3.3 levels in histone extracts from somatic
tissues of 3-month-old and 24-month-old C57BL/6J mice. Total histone H3 and Ponceau S staining were used as loading controls. (B) Overview of
the middle-down proteomics workflow used in the study. Histones were acid extracted from mouse tissues and digested with endopeptidase GluS (1).
The resulting peptide mixtures containing 50 aa residues long H3 N-terminal peptides were analyzed by on-line nano-LC–MS/MS method using weak
cation exchange–hydrophilic interaction liquid chromatography (WCX-HILIC) for peptide separation and electron transfer dissociation (ETD) for their
fragmentation (2). Acquired MS/MS data were searched against a histone protein database to obtain a set of peptide identifications followed by filtering
out of hits with ambiguous PTM site assignments (3). Peptides with unambiguous PTM localizations were quantified based on the total ion current of
their MS/MS spectra (MS2-TIC). Obtained quantitative results were used to calculate the relative abundances of distinct H3 proteoforms barring single or
combinatorial PTMs, where the sum of all MS2-TIC intensities was considered as 100% (4). The relative abundance of each individual H3 PTM and each
H3 variant was calculated by summing up the relative abundances of all H3 proteoforms containing the given PTM or assigned to the given H3 variant,
respectively (5). The relative abundance of individual PTMs on H3.3 was calculated as the sum of the relative abundances of H3.3 proteoforms containing
the given PTM normalized by the relative abundance of the H3.3 variant. For more details, see the ‘Materials andMethods’ section. (C) Dynamics of H3.3
accumulation in chromatin of various mouse somatic tissues with age as revealed by middle-downMS analysis. Error bars indicate SD (n = 2–4 biological
replicates).
or combinatorial PTMs (Figure 1B, Supplementary Figure
S1) (41,42). In agreement with the report by Maze et al.
(31), we found that H3.3 progressively accumulates in the
mouse brain during adulthood resulting in near complete
replacement of canonical H3.1/2 isoforms by the age of 18
months (Figure 1C). Interestingly, a nearly identical accu-
mulation pattern for H3.3 was observed in liver and kidney
tissues, where H3.3 levels exceeded 99% and 94% of the to-
tal H3 pool, respectively, by the age of 18 months. In the
heart, the accumulation rate of H3.3 was slower with 76%
of canonical H3.1/2 isoforms been replaced by the H3.3
at 24 months of age (Figure 1C). Although the molecu-
lar mechanisms modulating histone variant exchange rate
remain undefined, previous studies demonstrated that H3
proteins bearing active PTMs, such as acetylation at dis-
tinct lysine residues, exhibit faster turnover than H3 bear-
ing repressive PTMs, such as methylation at K9 and K27
(50). Hence, we next compared the relative abundances of
these PTMs between the heart and other somatic tissues.
We found that heart chromatin is significantly enriched in
repressive H3 PTMs, including H3K9me2 and H3K27me3,
and is depleted in active H3 PTMs, including H3K14ac,
H3K18ac and H3K23ac, as compared to liver, kidney and
brain chromatin (Supplementary Figure S2). In line with
the slower H3.3 accumulation rate observed in heart, these
data link the global rate of H3 variant replacement with
age to cell type-specific H3 PTM landscape. On the one
hand, the low abundance of active H3 PTMs that are asso-
ciated with fast histone turnover might slow down the H3
variant replacement rate with age. Alternatively, consider-
ing the fact that H3.3 variant is enriched in active PTMs
(51), the lower abundance of these PTMs in the heart as
compared to other tissues might be a consequence of the
lower level of H3.3 in this tissue. Taken together, our results
identify progressive age-dependent replacement of canoni-
cal H3.1/2 isoforms by the H3.3 variant as a common fea-
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Figure 2. H3.3 is enriched in non-tumor human hepatocytes but is de-
pleted in hepatocarcinoma cells (A) Schematic model depicting the puta-
tive difference inH3 variant dynamics between healthy tissues with low cell
proliferation rates (such as liver) and their highly proliferating tumor coun-
terparts. * RI – replication-independent. (B) Relative abundance of histone
H3 variants in primary human hepatocytes and C3A/HepG2 cell line as
revealed by middle-down MS analysis. (C) Immunoblot analysis of H3.3
level in whole-cell extracts from human hepatocellular carcinoma (HCC)
tissues and adjacent non-tumor (NT) liver tissues derived from five indi-
vidual patients. Representative western blot pictures and semi-quantitative
data are presented. Total H3 was used as loading control and for normal-
ization. (*) Cirrhosis liver; (**) proteolytically processed H3 proteoforms
(42,46). (D) Relative abundance of H3 variants in pooled HCC and pooled
NT samples as revealed by quantitative targeted bottom-up MS analysis.
ture of chromatin organization in somatic mouse cells and
indicate that H3.3 accumulates to near saturation levels by
the late adulthood, except for the heart where H3.3 accu-
mulation proceed throughout life.
H3.3 is depleted in tumor tissues as compared to adjacent
non-tumor tissues
Given our finding that age-dependent replacement of
H3.1/2 with H3.3 in mouse cells is not restricted to non-
dividing post-mitotic tissues, such as heart and brain, but
also occurs in slow-dividing mitotic tissues, such as liver
and kidney, we next hypothesized that the relative abun-
dance of H3 variants might reflect the proliferating status
of the latter ones. Specifically, we hypothesized that, while
the chromatin of slow-dividing tissues would be preferen-
tially marked byH3.3 when these tissues are in homeostasis,
i.e. have a low cell turnover rate, the level of H3.3 will de-
crease markedly if they become abnormally proliferating,
such in the case of cancer (Figure 2A). Given the fact that
each time the cell divides it doubles the amount of histones
by expressing canonical H3 isoforms, we hypothesized that
active cell proliferation would lead to overall dilution of the
H3.3 variant with H3.1/2 isoforms being incorporated into
chromatin through the replication-dependent (RD) nucleo-
some assembly pathway. To test this we first compared the
relative abundance of H3 variants in primary human hep-
atocytes derived from healthy human liver and hepatocel-
lular carcinoma cell line HepG2/C3A using quantitative
MS analysis. In agreement with our hypothesis, H3.3 repre-
sented over 99%of the totalH3 pool in primary human hep-
atocytes (Figure 2B), which was consistent with our results
obtained from mouse liver, while the relative abundance of
H3.3 in the HepG2/C3A cell line was only 1.5%. To eval-
uate whether the relative abundance of H3 variants can be
potentially used as a biomarker of abnormal cell prolifera-
tion activity in vivo, we next compared the relative abun-
dance of H3.3 between human hepatocellular carcinoma
(HCC) tissues and adjacent non-tumor (NT) liver tissues
obtained from five individual patients. Western blot analy-
sis with H3.3-specific antibodies demonstrated pronounced
enrichment of H3.3 in NT samples as compared to HCC
samples in four out of five cases (Figure 2C). These results
were further validated by targeted MS analysis that showed
that the relative abundance of H3.3 was about five times
higher inNT samples as compared toHCC samples (Figure
2D).Notably, the pair of tumor and adjacent non-tumor tis-
sues that demonstrated similar levels of H3.3 was obtained
from the patient diagnosed with liver cirrhosis, a condition
that was previously associated with elevated hepatocytes
proliferation activity (52). Collectively, these results suggest
that the relative abundance of H3 variants can be used as
a biomarker for abnormal cell proliferation activity in vivo
and highlight its potential utility as a tumor biomarker.
Accumulation of H3.3 with age is accompanied by profound
changes in the global levels of H3 methyl modifications
There is increasing evidence that H3.3 is functionally dis-
tinct from its canonical counterparts H3.1 and H3.2 (36).
The amino acid sequence variations among the H3 variants
were recently found to directly affect the deposition and
recognition of PTMs on H3 N-terminal tails. In Arabidop-
sis thaliana, the histone methyltransferase ATXR5 selec-
tively monomethylates K27 on histone H3.1 but not on the
H3.3 variant (38). In mammals, candidate tumor suppres-
sor ZMYND11 selectively recognizes K36me3 onH3.3 and
co-localizes with H3.3K36me3 within gene bodies (35,37).
These findings raise the possibility that histone H3 variant
replacement may affect the levels of H3 PTMs and their
functional readout. To explore this idea, we investigated
whether progressive replacement of H3.1/2 isoforms with
H3.3 inmouse cells is accompanied by changes in the global
levels ofH3 PTMs.We quantified the relative abundances of
28 distinct H3 PTMs at 5 time points across the mouse lifes-
pan using middle-downMS (Supplementary Table S1, Sup-
plementary Figure S3). QuantitativeMS analysis revealed a
number of H3 PTMs, including methylation at distinct ly-
sine and arginine residues, whose relative abundances were
significantly altered with age (Figure 3A). Remarkably, the
relative abundances of several PTMs exhibited a similar pat-
tern of change in all analyzed tissues and these changes
were concurrent with an accumulation of H3.3. The rela-
tive abundance of H3K36me2 in liver and kidney gradu-
ally increased by ∼110% and ∼60%, respectively, from 3
to 10 months of age and remained relatively stable there-
after (Figure 3B). In the heart, the relative abundance of
H3K36me2 demonstrated an increasing trend over the en-
tire time course consistent with a continuous accumulation
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Figure 3. Middle-down mass spectrometry reveals distinct, dynamic changes in the relative abundances of individual H3 PTMs during mouse lifespan.
(A) Dynamic changes in H3 PTM abundances in somatic mouse tissues with age (3–24 months). The heat map shows hierarchical clustering of the log2
transformed fold changes in H3 PTM abundances at indicated time points relative to those at 3 months of age. Significantly up- and down-regulated PTMs
(Limma test with Benjamini-Hochberg correction for multiple comparisons) are indicated by black boxes (continuous line for P < 0.05; dashed line for
P < 0.1) as shown in the color key. (B–D) Relative abundances of H3 PTMs that demonstrated a similar pattern of change with age in different tissues.
The level of H3K36me2 increases during the adulthood (months 3–10) (B) and correlates with the relative abundance of H3.3 (E). The level of H3R17me2
decreases during the adulthood (months 3–10) (C) and correlates with the relative abundance of H3.3 (F). The level of H3K9me2 decreases during the
adulthood (months 3–10) in liver and kidney tissues (D). H3K4me1 is upregulated in tissues derived from 24-month-old mice (G). Error bars indicate SD
(n = 2–4 biological replicates).
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of H3.3. A similar increase with age was observed for the
relative abundance of H3K36me3 (Supplementary Figure
S4A). By contrast, the relative abundance of H3R17me2, a
PTM which was previously associated with transcriptional
activation (53,54), gradually decreased during the first 10
months of animal life in liver, kidney and brain and dur-
ing the 24 months in the heart (Figure 3C). A similar de-
creasing trend was observed for the relative abundance of
H3K9me2, which dropped by 30% and 40% by the age of
10 months in kidney and liver tissues, respectively, and by
24% by the age of 24 months in heart (Figure 3D); the rel-
ative abundance of H3K9me2 in brain remained at the sta-
ble level throughout the mouse lifespan. Notably, the rel-
ative abundances of two age-regulated PTMs, H3R17me2
and H3K36me2, were strongly correlated with the relative
abundance of H3.3, suggesting that changes in the levels of
these PTMsmight be directly associated with accumulation
of H3.3 (Figure 3E and F).
Unlike H3 PTMs that were up- or down-regulated con-
currently with an accumulation of H3.3, H3K4me1 dis-
played a pattern of change, which was strongly associated
with the late aging period. The level of H3K4me1 remained
relatively stable during the first 18 months of mouse life but
increased by 3–4-fold in all analyzed tissues derived from
24-month-old animals (Figure 3G). The drastic increase in
the level of H3K4me1 in aged mice can potentially be ex-
plained by the well-documented age-dependent decline in
DNA methylation in rodents, which is, in turn, associated
with the appearance of H3K4me1 (55,56).
Some H3 PTMs, such as H3K9me3, H3R26me1 and
H3K27me2/me3, were only regulated in one or two tis-
sues or demonstrated a distinct pattern of change be-
tween tissues, suggesting the cell type-specific character of
these chromatin rearrangements (Figure 3A; Supplemen-
tary Figure S4). Finally, in contrast to methylation, the
level of H3 acetylation remained relatively stable across the
entire mouse lifespan, indicating that this type of mod-
ification is less susceptible to age-dependent changes in
chromatin organization (Figure 3A; Supplementary Figure
S4). The relative abundances of H3K14ac, H3K18ac and
H3K23ac demonstrated a modest (<1.6-fold), yet insignifi-
cant, increase, while the relative abundances ofH3K9ac and
H3K27ac oscillated between 1% to 3% with no consistent
pattern of change (Supplementary Figure S4, Supplemen-
tary Table S1). Collectively, these results provide the first
comprehensive quantitative characterization of dynamic
changes in relative abundances of individual H3 PTMs dur-
ing the mouse lifespan and demonstrate that histonemethy-
lation, which is traditionally viewed as a relatively stable epi-
genetic mark (57), undergoes profound changes in somatic
tissues with age concurrently with progressive replacement
of H3.1/2 by the H3.3.
A distinct dynamics of PTM levels on H3.3 throughout lifes-
pan suggests a causative relationship between H3 variant re-
placement with age and accumulation of H3K36me2
Given our finding that H3.3 accumulation is concurrent
with profound changes in the relative abundances of sev-
eral H3 methyl PTMs, we next hypothesized that H3 vari-
ant replacement might be directly involved in modulating
the levels of these PTMs with age. If replacement of canon-
ical H3.1/2 isoforms by the H3.3 variant alters the PTMs
pattern present on chromatin, then we presumed that the
following criteriamust be fulfilled: (i) the relative abundance
of PTMs should be different between H3.3 and H3.1/2; (ii)
the relative abundance of PTMs on H3.3 should be inde-
pendent of H3.3 level in the chromatin and H3.3 genomic
distribution. The latter is important to distinguish between
two possible scenarios (Figure 4). First, given the fact that
H3.3 variant and H3 PTMs are not uniformly distributed
across the genome,H3.3 can exhibit distinct levels of certain
PTMs (different from those for H3.1/2) due to its preferen-
tial localization within genomic regions that are specifically
enriched (depleted) in these PTMs independent of whichH3
variant is deposited at these regions. This scenario relies on
the fact that H3.3 tend to associate with active chromatin
regions exhibiting fast H3 turnover, such as promoters and
enhancers (58). If this scenario is correct, then the relative
abundances of the PTMsonH3.3would be dependent on its
genomic distribution and would change concurrently with
its genome-wide spread with age (Figure 4, ‘scenario 1’).
The global levels of PTMs on total H3 would, in contrast,
remain stable and would be unaffected by theH3 variant re-
placement with age. The second scenario implies that a cer-
tain PTM(s) can be specifically enriched/depleted on H3.3
due to the functional distinctness between H3 variants and
regardless of their genomic distributions. For example, a
certain enzyme can preferentially modify only one of the
H3 variants, as was recently shown forH3.1-specificmethyl-
transferase ATXR5 (38). If this scenario is correct, then the
relative abundance of the PTM(s) on H3.3 would be sta-
ble and independent of its distribution across the genome
and its level in the chromatin (Figure 4, ‘scenario 2’). In
this case, H3 variant replacement would directly affect the
global level of the PTM(s).
To test whether H3.3 meets the criteria described above
we determined the relative abundances of PTMs onH3 vari-
ants at 5 time points across themouse lifespan usingmiddle-
downMS (Supplementary Table S2). In a first step, we com-
pared the relative abundances of PTMs between H3 vari-
ants in tissues derived from young mice where H3.3 repre-
sented 10–40% of the total H3 pool (Figure 5A, left panel).
In agreement with previous reports, we found that H3.3
exhibits 2–8 times higher level of acetylation at K14, K18
and K23 compared to H3.1/2 (Supplementary Figure S5)
(51,59). H3.3 was also enriched in K23me3 and K36me2.
In contrast, the two well-known heterochromatin PTMs,
K9me2 and K27me3, as well as transcription-associated
arginine methylations, R17me2 and R26me1, were enriched
on canonical H3.1/2 isoforms (Figure 5A, left panel; Sup-
plementary Figure S5).
To gain insight into potential causes of the differences
in PTM levels between H3 variants, we examined whether
and how the relative abundances of PTMs on H3.3 change
with increasingH3.3 level andmouse age. The relative abun-
dances of the majority of PTMs on H3.3 showed signif-
icant changes with age-dependent accumulation of H3.3
(Figure 5A, right panel), suggesting that these PTMs are
likely associated with specific chromatin regions rather than
with H3.3 or H3.1/2 variants themselves (Figure 4, ‘sce-
nario 1’). The relative abundances of PTMs that were en-
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Figure 4. Two possible scenarios for the relationship between H3 variant replacement and H3 PTMs dynamics. Scenario 1: H3 PTMs are associated with
specific chromatin regions regardless of which H3 variant is deposited at these regions (left panel). Replacement of canonical H3.1/2 isoforms by the H3.3
variant does not affect global levels of H3 PTMs. Relative abundances of PTMs on H3.3 change consistently with an accumulation of H3.3. Scenario 2: H3
PTMs are associated with H3.3 variant (right panel). Replacement of canonical H3.1/2 isoforms by the H3.3 variant is associated with changes in global
levels of H3 PTMs. Relative abundances of PTMs on H3.3 remain stable after H3.3 accumulation.
riched on H3.3 compared to H3.1/2 at 3 months of age,
such as K23ac and K23me3, decreased on H3.3 consis-
tently with the increase in the level of this histone variant
with age (Figure 5A and C; Supplementary Figure S6). By
contrast, the relative abundances of PTMs that were de-
pleted on H3.3 at 3 months of age, such as K9me2 and
R26me1, showed an increase on H3.3 with age (Figure 5A
and B; Supplementary Figure S6). Collectively, these find-
ings suggest that the differences in the relative abundances
of K9me1/me2, K14me1/me2/ac, K18ac, K23me3/ac and
K26me1 between H3.1/2 and H3.3 variants at 3 months of
age were likely arising from the difference in their genomic
distributions. Interestingly, the relative abundances of 3 out
of 28measured PTMsonH3.3, includingK36me2,K27me2
and K27me3, remained stable throughout the entire mouse
lifespan and independent of the H3.3 level in chromatin
(Figure 5A, D–E). This, together with the fact that K36me2
was highly (up to 4-fold) enriched on H3.3 as compared to
H3.1/2 (Supplementary Figure S5), indicate that the higher
level of K36me2 on H3.3 is likely not dictated by the H3.3
genomic distribution but rather can be attributed to the spe-
cific property of the H3.3 variant itself (Figure 4, ‘scenario
2’). We, therefore, propose that the increase in the global
level of H3K36me2 with age is likely driven by the pro-
gressive replacement of H3.1/2 with the H3.3 variant (Fig-
ure 5F). Unlike K36me2, K27me2 and K27me3 exhibited
relatively similar relative abundances on both H3 variants
(≤1.8 - fold difference). K27me2 demonstrated a modest,
yet insignificant, enrichment on H3.3, while K27me3 was
enriched on H3.1/2. The most profound difference in the
levels of these PTMs between H3 variants was observed in
liver chromatin, where the relative abundances of K27me2
and K27me3 on H3.3 were 1.7-times higher and 1.8-times
lower, respectively, as compared to H3.1/2. Consistently
with this, replacement of H3.1/2 by the H3.3 in liver was
associated with a partial switch from tri- to dimethylation
state at K27 (Supplementary Figures S3 and S4). However,
the levels of H3K27me2 and H3K27me3 in other tissues
remained relatively stable throughout the lifespan. Collec-
tively, these findings suggest a causative relationship be-
tween theH3 variant replacement with age and the dynamic
changes in the global level of H3 methylation, including an
increase in the level of H3K36me2 observed in liver, kidney
and heart chromatin and a decrease in the level of K27me3
observed in liver chromatin.
H3 variant replacement with age is associated with profound
changes in combinatorial H3 PTMs
The N-terminal tails of histone proteins are often deco-
rated by multiple PTMs that form distinct combinatorial
modification patterns (60). Importantly, different combi-
nations of coexisting PTMs can promote distinct biological
outcomes indicating that at least some of the regulatory
effects of histone PTMs are mediated by their cooperative
action. However, our knowledge about the combinatorial
histone modification landscape and its temporal changes
Downloaded from https://academic.oup.com/nar/article-abstract/45/16/9272/4067254/Accumulation-of-histone-variant-H3-3-with-age-is
by Danish Regions user
on 17 October 2017
Nucleic Acids Research, 2017, Vol. 45, No. 16 9281
Figure 5. Relative abundances of PTMs on H3.3 exhibit distinct pattern of change with age. (A) Left panel: the heat map shows the difference in the
relative abundances of PTMs between H3.3 and H3.1/2 isoforms in tissues derived from 3-month-old mice. Differentially abundant PTMs (paired t-test
with Benjamini-Hochberg correction for multiple comparisons) are indicated by black boxes (continuous line for P < 0.05; dashed line for P < 0.1) as
shown in the color key. Right panel: the heat map shows the log2 fold change in the relative abundances of PTMs on H3.3 at the indicated time points as
compared to those at 3 months of age. Data shown in (B–E) are for liver tissue. (B) Relative abundance of H3.3K9me2 increases with age consistently with
an accumulation of H3.3. (C) Relative abundance of H3.3K23ac decreases with age consistently with an accumulation of H3.3. (D–E) Relative abundances
of H3.3K36me2 (D) and H3.3K27me3 (E) remain stable independently of mouse age and H3.3 relative abundance. For H3.3 PTM dynamics in kidney,
brain and heart tissues see Supplementary Figure S6. (F) A putative model illustrating the causal relation between H3 variant replacement with age and
increase in the global level of H3K36me2.
during mammalian development and aging still remains
very limited. To fill this gap, we took advantage of our
middle-down MS platforms and performed an extensive
quantitative analysis of the dynamic changes in combina-
torial H3 PTMs throughout mouse lifespan. We identified
and quantified from 200 to over 600 distinct combinatorial
PTMs present on the H3 N-terminal tails in four mouse
tissues at five different ages (Figure 6A). Among those,
57 H3 PTMs were reproducibly detected in all analyzed
biological samples. Many of these PTMs were highly abun-
dant (relative abundance> 1%) and together accounted for
53–76% of all quantified H3 peptides depending on tissue
type and mouse age (Figure 6A). The top five most abun-
dant combinatorial H3 PTMs at 3 months of age included
H3K9me2K27me3, H3K9me1K14me1K27me2K36me2,
H3K27me3 (given the fact that this single modifica-
tion reflects specific H3 modification state where all
residues except for K27me3 are unmodified (un), i.e.
K4unK9unK14unK23unK27me3K36un, we considered
it along with combinatorial PTMs), H3K27me2K36me2
and H3K9me2K14acK27me3 (Supplementary Figure
S7A). Among those, H3K9me2K27me3 represented the
most abundant combinatorial PTM in all analyzed tissues
(relative abundance ranging from 5% to 18%) except for
the brain. In the brain, the most abundant combinatorial
PTM was H3K9me1K14me1K27me2K36me2 with the
relative abundance of 8% (Supplementary Figure S7C).
Notably, approximately 100 most abundant combinatorial
PTMs in each tissue accounted for 90% of all quantified
H3 peptides, while the remaining several hundred lower
abundant PTMs accounted for only 10% of the H3 peptides
(Figure 6B). On one hand, these data illustrate the great
complexity of combinatorial PTM patterns present on the
H3 N-terminal tails; on the other hand, it indicates that the
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Figure 6. Combinatorial H3 PTM landscape undergoes dynamic changes with age. (A) The total numbers of distinct combinatorial H3 PTMs identified
and quantified by the middle-down MS in four mouse tissues at the five indicated time points. 57 combinatorial PTMs were reproducibly detected in all
biological samples. Relative abundances of H3 proteins marked by one of the 57 common or by one of remaining PTMs in each sample are indicated by
grayscale shading as shown in the color key. (B) The cumulative relative abundance of combinatorial H3 PTMs ranked according to their abundance. (C)
Left panel: the heat map shows the log2 fold change in relative abundances of 57 common combinatorial PTMs at the indicated time points as compared
to those at 3 months of age. Statistically significant differences (P < 0.1, Limma test with Benjamini-Hochberg correction for multiple comparisons)
are indicated by black dots. Central panel: the heat map shows the relative abundances of 57 common H3 combinatorial PTMs at the indicated time
points. Right panel: the heat map shows the difference in average relative abundance of 57 common H3 combinatorial PTMs between H3.3 and H3.1/2
isoforms in tissues derived from 3- and 5-month-old mice. H3.3- and H3.1/2-enriched PTMs (P< 0.05, paired t-test with Benjamini–Hochberg correction
for multiple comparisons) are shown in cyan and orange, respectively; non-significant differences are indicated by gray crosses. Relative abundances of
H3K27me2K36me2 (D) and H3K9me2K36me3 (E) increase with age in all analyzed tissues, while the relative abundance of H3K9me1K14me1K27me2.
(F) decreases with age. The relative abundance of H3K9me2K27me3 (G) decreases in liver and kidney chromatin.
Downloaded from https://academic.oup.com/nar/article-abstract/45/16/9272/4067254/Accumulation-of-histone-variant-H3-3-with-age-is
by Danish Regions user
on 17 October 2017
Nucleic Acids Research, 2017, Vol. 45, No. 16 9283
vast majority of chromatin is decorated by a very limited
number of abundant combinatorial H3 modifications.
We next investigated whether and how the relative abun-
dances of combinatorial H3 PTMs change with age. We
focus on 57 PTMs that were reproducibly quantified by
MS in all analyzed biological samples. Among those, nine
PTMs demonstrated significant increase with age in at
least two different tissues (Figure 6C). The most pro-
found increase in the PTM level between 3- and 24-month-
old mice was observed for H3K27me2K36me2 which rel-
ative abundance raised from ∼4% to 9% and from 4%
to 15% in liver and kidney tissues, respectively, from 7%
to 14% in brain and from 0.4% to 6% in heart (Fig-
ure 6D). A similar pattern of change was observed for
H3R26me2K36me2 and H3K27me3K36me1, which rela-
tive abundances demonstrated a several fold increase with
age in all analyzed tissues. Interestingly, while the relative
abundance of H3K27me3K36me1 in liver increased from
0.2% at 3 months of age to 2.4% at 10 months (Figure
6C), the relative abundance of H3K27me3 demonstrated
the opposite pattern of change and dropped from 46% to
23% (Supplementary Figure S4). A similar discordance was
observed for H3K9me2K36me3 whose relative abundance
showed 5–10 times increase with age in all analyzed tis-
sues (Figure 6E) and H3K9me2 whose relative abundance
dropped during the same period by 20–34% (Figure 3D).
These results indicate that the relative abundances of in-
dividual H3 PTMs and combinatorial H3 PTMs involv-
ing these individual PTMs can exhibit distinct dynamics
with age. Other combinatorial PTMs that exhibited a sig-
nificant increase in abundance with age included H3K4me
1K9me1K14acK27me2K36me2, H3K23acR26me2K36me
2, H3K23acK27me2K36me2, H3K18acK23acK27me2K3
6me2 and H3K14acK18acK27me2K36me2. Of note, five
out of nine combinatorial PTMs that were upregulated
with age contained both K27me2 and K36me2, indicating
a drastic increase in the level of K27me2K36me2-modified
H3 N-terminal tails in the chromatin of middle-aged and
oldmice (this observation is discussed below inmore detail).
In contrast to PTMs listed above, the relative abundances
of H3K27me1K36me2, H3K9acK14me3K27me2K36me2,
H3K9me2K14acK27me3 and H3K9me1K14me1K27me2
demonstrated consistent decrease with age in at least three
different tissues (Figure 6C and F). Similarly, the relative
abundance of H3K9me2K27me3 dropped from 18% and
12% at 3 months of age to 7% and 4% at 24 months in
liver and kidney tissues, respectively, while, in heart and
brain, it oscillated in a range of 13–21% and 3–6%, re-
spectively, with no clear pattern (Figure 6D). Collectively,
these changes resulted in a prominent reorganization of the
combinatorial H3 PTM landscape in the chromatin of aged
mice. In contrast to young mice, where the most abundant
combinatorial PTMwas H3K9me2K27me3, the chromatin
of 24 months old animals was preferentially decorated by
H3K27me2K36me2 that represented the most abundant
combinatorial PTM in all tissues except for heart (Sup-
plementary Figure S7B). In the heart, the most abundant
combinatorial PTM was H3K9me2K27me3 (Supplemen-
tary Figure S7D). The other abundant PTMs in the chro-
matin of aged mice included H3K9me2K27me3K36me1,
H3K9me1K14me1K27me2K36me2 and H3K27me3.
Wenext aimed to evaluate the possible causal relationship
betweenH3 variant exchange and dynamic changes in com-
binatorial H3 PTM landscape with age. Following the same
logic as above (Figure 4), we first compared the relative
abundances of combinatorial PTMs between H3 variants
in tissues isolated from 3 months old mice. We identified 85
and 58 combinatorial PTMs that were significantly enriched
on H3.3 and H3.1/2, respectively, in at least one mouse
tissue (Supplementary Figure S8). Among those, 10 and
8 PTMs demonstrated consistent enrichment on H3.3 and
H3.1/2, respectively, in all analyzed tissues. Next, we evalu-
ated whether and how the relative abundances of these com-
binatorial PTMs on H3.3 changes with mouse age concur-
rent with an accumulation of H3.3. Most of the combinato-
rial PTMs that were specifically enriched (depleted) onH3.3
in chromatin of youngmice––whenH3.3 occupied only very
limited part of the chromatin––lost the H3.3-enriched (de-
pleted) profile when H3.3 spread to nearly entire chromatin
with age (Supplementary Figures S9–S12). These data indi-
cate that similar to the individual H3 PTMs, the majority
of combinatorial H3 PTMs are likely associated with spe-
cific genomic regions (chromatin domains) rather than with
H3.3 or H3.1/2 variants themselves (Figure 4, scenario 1).
Interestingly, several PTMs, such as H3K27me2K36me2,
R26me2K36me2 and H3K27me3K36me1, remained stably
enriched on H3.3 throughout the entire mouse lifespan and
independent of H3.3 abundance in the chromatin (Supple-
mentary Figures S9–S12), indicating that they might be di-
rectly associated with H3.3 regardless of where it deposited
in the genome (Figure 4, scenario 2). These results suggest
a causative link between the dynamic increase in the global
levels of these combinatorial PTMs with age and accumu-
lation of H3.3. In total, six out of nine PTMs that were sig-
nificantly upregulated with age also demonstrated specific
enrichment on H3.3 in at least two different tissues (Fig-
ure 6C, right panel). The quantitative information on com-
binatorial H3 PTM abundances for each analyzed mouse
tissue is publicly available in the CrossTalkDB repository
at http://crosstalkdb.bmb.sdu.dk. Collectively, our findings
indicate that the relative abundances of combinatorial H3
PTMs undergo dynamic changes duringmouse lifespan and
suggest that some of these changes might be driven by the
H3 variant replacement with age.
Global levels of H3 methylation at K9, K27 and K36 are
strongly correlated with each other
Histone PTMs are known to affect each other by attract-
ing or repelling different histone modifying enzymes, such
as modification ‘writers’ and ‘erasers’. For example, methy-
lation of H3K36 was found to antagonize PRC2-mediated
methylation of H3K27 (61). Along with other examples,
histone PTM crosstalk is emerging as an important reg-
ulatory mechanism for modulating chromatin states and
transcriptional activity (62). Yet, very few studies have in-
vestigated the functional relation between distinct histone
PTMs on the large scale. Hence, we next aimed to evalu-
ate the possible crosstalk between various H3 N-terminal
PTMs using the quantitative data on combinatorial H3
PTMs defined by middle-down MS and our previously de-
scribed mathematical model (45). Briefly, we compared the
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observed co-frequencies of binary histone PTMs to their
expected co-frequencies calculated based on the assump-
tion that the two modifications in each pair are indepen-
dent of each other. The expected co-frequency of binary
modification AB was therefore calculated by multiplying
the relative abundances of modification A by modification
B. To evaluate the crosstalk between two histone PTMs we
used interplay score, calculated as log2(observed frequency
of binary PTM/expected frequency of binary PTM), where
highly negative interplay values indicate that the two PTMs
are mutually exclusive, while positive interplay values sug-
gest codependency of the two PTMs (for more details see
Materials and Methods). Using this model we evaluated
the possible crosstalk between 19 distinct H3 PTMs repre-
senting the major acetylation and methylation events (rel-
ative abundance ≥ 2%) on the H3 N-terminal tail (Fig-
ure 7A). Our analysis confirmed a number of previously
described PTM crosstalks, such as the mutually exclusive
relation between H3K9me3, H3K27me3 and H3K36me3,
and revealed several previously uncharacterized relation-
ships between H3 PTMs, such as the positive interplays be-
tween H3K9me2 and H3K36me3 and between H3K9me3
andH3K14ac (Figure 7A). The latter two examples are par-
ticularly interesting as they involve PTMs that are gener-
ally believed to have the opposite effect on gene expression,
where H3K9me2 and H3K9me3 are associated with re-
pressed chromatin state and H3K14ac and H3K36me3 are
associated active loci. Although the functional significance
of co-occurrence of H3K9me3 and H3K14ac on the same
H3 tails is unclear, a recent ChIP-seq study inmouse embry-
onic stem cells (mESCs) showed that H3K14ac colocalizes
with H3K9me3 on a subset of inactive promoters, suggest-
ing that the combination of these PTMs might be involved
in the dynamic transcriptional regulation (63). Although
unexpected, the co-enrichment of K9me2 and K36me3 on
the same H3 tails was consistent with a previous study
showing that H3K36me2 exhibits profound enrichment at
different heterochromatin domains marked by H3K9me2
(64).
Notably, the majority of PTM pairs demonstrated the
similar interplay values in all analyzed tissues and in all
age groups indicating that PTM crosstalk on H3 is con-
served between different somatic cell types as well as during
postnatal mammalian development (Supplementary Figure
S13).We also observed a close correlation between the inter-
play values for PTM pairs present on H3.1/2 and H3.3 sug-
gesting that the functional relationship betweenH3PTMs is
largely independent of whichH3 variants they are deposited
on (Supplementary Figure S14).
We next aimed to investigate in more detail the re-
lation between H3 PTMs that form the most abundant
combinations occupying the majority of H3 tails. The
top three pairs of PTMs that showed the highest co-
frequencies were K27me2K36me2, K9me2K27me3 and
K9me1K27me2 (Figure 7B). Expectedly, these PTM pairs
involved highly abundant individual PTMs that exhibited
positive interplay between each other. Consistently with the
difference in the relative abundances of individual PTMs be-
tween H3 variants, the co-frequency for K27me2K36me2
was higher on H3.3 as compared to that on H3.1/2,
while K9me2K27me3 was, in contrast, more abundant on
H3.1/2. Interestingly, despite the fact that the PTMs in
these pairs exhibited positive interplay with each other on
both H3 variants, the absolute overlap between them, i.e
the proportions of H3 tails modified with PTM ‘A’ that also
bear PTM ‘B’, demonstrated substantive difference between
H3.3 and H3.1/2 (Figure 7C, Supplementary Figure S15).
Specifically, while about 80–90% of all K27me2-modified
H3.3 tails were also bearing K36me2, and vice versa, about
80% of K36me2-modified H3.3 tails were bearing K27me2,
the prominent overlap between these PTMs were partially
disrupted on H3.1/2. In the case of H3.1/2, about 90% of
all K36me2-modified histone tails were bearing K27me2,
but only about 50% K27me2-modified tails were bear-
ing K36me2. These results indicate that while K27me2
and K36me2 nearly always appear together on H3.3, a
substantial proportion of H3.1/2 bear K27me2 without
K36me2. Notably, we observed very little overlap between
binary PTMs K9me2K27me3 and K27me2K36me2, i.e.
both K9me2 and K27me3 very rarely coexisted with either
K27me2 or K36me2 and vice versa (Figure 7C).
Although the interplay score provides a useful metric for
predicting possible functional cross-talk between histone
PTMs, it has a major limitation in terms of positive pre-
dictive value. The fact the two PTMs co-localize on the
same histone tail much more or much less often than if they
were distributed in chromatin independent of each other
does not necessarily imply that they exhibit positive or neg-
ative functional crosstalk with each other. In order to fur-
ther evaluate the functional relationship between distinct
H3 PTMs, we performed a correlation analysis between the
global levels of H3 PTMs using the quantitative MS data
obtained from the analysis of different mouse tissues at dif-
ferent ages (Figure 7D). We presumed that if two PTMs
exhibit positive (or negative) crosstalk, i.e. one PTM fa-
cilitate the deposition (or removal) of the other one, then
the relative abundances of these PTMs should be positively
(or negatively) correlated. We identified six pairs of PTMs
which relative abundances were closely correlated (R> 0.9)
with each other (Figure 7E and F), suggesting that one
PTM in each pair might be functionally affecting the other
one. Of note, the pairs of PTMs that demonstrated positive
correlation, including H3K9me2-H3K27me3, H3K9me1-
H3K27me2 and H3K27me2-H3K36me2, were identical to
the top three most abundant binary H3 PTMs described
above. Unlike PTMs that demonstrated codependency,
some of the abundant PTMs seemed to compete with each
other for occupying the H3 N-terminal tail. Specifically,
a strong negative correlation was found between the rela-
tive abundances of H3K27me2 and H3K27me3, H3K9me2
and H3K27me2 and between H3K9me2 and H3K36me2
(Figure 7F). This was in agreement with the fact that these
PTMs are almost never colocalized together on the sameH3
molecules (Figure 7C). Interestingly, a similar negative cor-
relation was observed between the relative abundances of
binary PTMs H3K9me2K27me3 and H3K27me2K36me2
(Figure 7G). In line with the fact these two binary PTMs
almost never overlap with each other (Figure 7C) and to-
gether occupy approximately 50% of all H3N-terminal tails
(which corresponds to 50–100% of the genome), these re-
sults suggest that they might serve as specific PTM sig-
natures separating the genome into two types of distinct
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Figure 7. Analysis of histone modification crosstalk reveals a strong correlation between global levels of H3 methyl marks. (A) The heat map shows
hierarchical clustering of interplay scores between H3 N-terminal PTMs. PTMs that tend to colocalize together (positive interplay values) or demonstrate
mutually exclusive profile (negative interplay values) are indicated by red and blue colors, respectively; the average PTMs abundances are indicated by
grayscale shading as shown in the color key. (B) Co-existence frequencies of the top three most abundant binary PTMs on total H3 and their co-existence
frequencies on H3.3 and H3.1/2. (C) The scheme depicts a co-occurrence network between individual H3 PTMs involved in the top two most abundant
binary PTMs specified in (B). (D) The heat map shows hierarchical clustering of Pearson’s correlation coefficients between relative abundances of H3
N-terminal PTMs among all analyzed histone samples. Positive and negative correlations are indicated by red and blue colors, respectively, as shown in
the color key; Pairs with strong correlation (|R| > 0.9) are outlined by black boxes. The average PTM abundances are shown as in (A). (E) Scatter plots
highlight pairs of H3 PTMs whose relative abundances exhibit strong positive or negative (F) correlation. (G) Relative abundances of the two binary PTMs,
H3K9me2K27me3 and H3K27me2K36me2, exhibit strong negative correlation, indicating the mutually exclusive relation between them. In line with the
distinct stable levels of H3K9me2K27me3 and H3K27me2K36me2 on H3.3 and H3.1/2, H3 variant replacement with age is associated with profound
changes in the global levels of these binary PTMs.
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chromatin states or non-overlapping chromatin domains.
Notably, both H3K27me2 and H3K36me2 demonstrated
higher co-occurrence frequencies with acetyl PTMs com-
pared to H3K9me2 and H3K27me3. Furthermore, the rel-
ative abundances of H3K27me2 and H3K36me2 were pos-
itively correlated with the level of H3 acetylation, while
the relative abundances of K9me2 and K27me3 demon-
strated a negative correlation with acetyl PTMs (Figure
7D). Hence, we speculate that H3K27me2K36me2 might
serve as a specific PTM signature of the open permissive
chromatin state, while H3K9me2K27me3 might represent
a PTM signature of the condensed restrictive chromatin
state. The latter is in agreement with previous observa-
tions showing that H3K9me2 and H3K27me3 colocalize
on the repressed chromatin (65). Notably, in line with a
stable enrichment of K9me2K27me3 and K27me2K36me2
on H3.1/2 and H3.3, respectively, H3 variant replacement
with age was associated with a decrease in the level of
K9me2K27me3-markedH3 tails andwith an increase in the
level of K27me2K36me2-markedH3 tails (Figure 7G). This
finding, together with the results described above, suggests
that H3 variant replacement with agemight play a causative
role in the dynamic changes in the H3 modification land-
scape during mouse lifespan.
DISCUSSION
Here, we provide the first comprehensive characterization
of the dynamic changes in histone H3 variant composition
and H3 modification landscape throughout the lifespan in
mice. The most prominent changes are summarized in Ta-
ble 2. Although it is well appreciated that histone variant
H3.3 replaces canonical H3.1/2 isoforms with age in mouse
brain tissue (31,49), the lifelong dynamics of H3 variant re-
placement in other tissue types has remained undefined.We
show that, similar to its enrichment profile in the mouse
brain, H3.3 exhibit age-dependent genome-wide accumu-
lation in other somatic tissues, including liver, kidney and
heart (Table 2). Using quantitative middle-down MS we
demonstrate that H3.3 accumulation rates vary between tis-
sues. In liver, kidney and brain, H3.3 progressively replaces
H3.1/2 isoforms during the adulthood and reaches satura-
tion levels, i.e. ≈99% of the total H3 pool, by the age of
18 months, while in heart the relative abundance of H3.3
increases throughout life and raises only up to 76% of to-
tal H3 by the age of 24 months. Given our finding that
heart chromatin exhibits specific H3 PTM profile which
was previously associated with slow H3 turnover rate (50),
we speculate that the global H3 variant replacement kinet-
ics might be at least partially modulated by the cell-type
specific H3 modification landscape. Together with previous
studies (31,32,49), our results indicate that progressive age-
dependent accumulation of H3.3 variant and consequential
loss of canonical H3.1/2 isoforms constitute a conserved
feature of chromatin organization in slow and non-dividing
cells. Although the physiological relevance of H3 variant
replacement with age remains largely undefined, a recent
study revealed the essential role of H3.3 in regulating pro-
longevity transcriptional programs in C. elegans (66). Fur-
thermore, lifelong H3.3 turnover was found to be involved
in the regulation of neuronal activity-dependent gene ex-
pression in mouse brain (31). Given our finding that H3.3
also accumulates in mouse liver, kidney and heart, it will be
of high relevance to investigate whether H3.3 plays a role in
the lifelong regulation of gene expression in these tissues.
In contrast to its genome-wide accumulation profile in
slow and non-dividing cells, H3.3 represents only a small
fraction of the total H3 pool in proliferating cell culture
models (59). Here we show that H3.3 is also highly de-
pleted in human hepatocarcinoma tissue compared to ad-
jacent non-tumor liver tissue. The difference in the rela-
tive abundances of H3.3 between actively proliferating tu-
mor and non/slow-proliferating non-tumor liver cells can
be explained by the fact that the level of H3.3 in chromatin
gets diluted during each round of cell division due to the
replication-coupled expression of canonical H3 and its de-
position into newly synthesized DNA strands. We, there-
fore, propose that the relative abundance of H3.3 can be
used as a biomarker of abnormal cell proliferation activ-
ity in vivo. The remarkable difference in H3.3 abundance
between slow-proliferating non-tumor and rapidly prolif-
erating tumor cells is particularly interesting in light of
the recent findings demonstrating the existence of histone
variant-specific PTM readers, such as the candidate tumor
suppressor protein ZMYND11 (35) and the transcription
factor ZMYND8 (67). It would be, therefore, important to
investigate whether and how the decline in H3.3 level in
cancer cells affects their transcriptional programs and chro-
matin properties.
Despite the fact that H3.3 differs from the canonical
H3.2 and H3.1 by only four and five amino acids, respec-
tively, it was hypothesized to directly affect chromatin orga-
nization (68). Consistently with this hypothesis, H3.3 was
shown to play an important role in maintaining a decon-
densed chromatin state and high levels of the open chro-
matin modifications––H3K36me2 and H4K16ac––in fer-
tilized mouse zygotes (69). Our study provides further ev-
idence that H3.3 can be involved in modulating the hi-
stone modification landscape. We show that the relative
abundances of a number of H3 PTMs, including both
individual and combinatorial modifications, undergo dy-
namic changes with age, concurrently with an accumulation
of H3.3 (Table 2). Remarkably, a subset of age-regulated
PTMs, including K36me2, exhibit stable enrichment on
H3.3, suggesting that the increase in their levels during the
lifespan might be directly associated with accumulation of
H3.3. Given the recent identification of H3.1 specific K27
methyltransferase inArabidopsis thaliana (38), we speculate
that the stable lifelong enrichment of K36me2 on H3.3 may
be due to preferentialmethylation ofH3.3 by anH3 variant-
specific yet undefined H3K36 methyltransferase.
Next, we provide a large-scale evaluation of the relation-
ship between 19 distinct H3 N-terminal PTMs. By compar-
ing co-frequencies for pairwise combinations of these PTMs
defined by MS with their co-frequencies calculated based
on the assumption that the two PTMs in each pair are in-
dependent of each other, we identify a number of modi-
fications demonstrating either mutually exclusive relation
or co-enrichment. Interestingly, the relative abundances of
several PTMs co-enriched of the same H3 tails, including
H3K9me2-H3K27me3 and H3K27me2-H3K36me2 pairs,
show strong positive correlation with each other, suggest-
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Table 2. A summary of the changes in H3 variant composition and H3 modification abundances with age. * ‘-‘ indicates that there is no clear pattern of
change or no significant difference
Changes in the relative abundances of H3 variants with age
H3 variant Change with age Tissues Note
H3.3 Increase Liver, kidney, brain,
heart
Enriched in non-tumor human liver tissue
H3.1/2 Decrease Liver, kidney, brain,
heart
Enriched in human hepatocellular carcinoma
tissue
Changes in the relative abundances of H3 PTMs with age




Change with age (on
H3.3)
Tissue(s)
Individual PTMs K36me2 Increase H3.3 Stable abundance Liver, kidney, brain, heart
K36me3 Increase - * - Liver, brain, heart
K27me2 Increase - Stable abundance Liver, Kidney
R26me2 Increase - - Brain, heart
K4me1 Increase - - Liver, kidney, brain, heart
R26me1 Increase H3.1/2 Increase Liver, brain
Decrease H3.1/2 Increase Heart
R17me2 Decrease H3.1/2 - Liver, kidney, brain, heart
K27me1 Decrease - - Heart
K27me3 Decrease H3.1/2 Stable abundance Liver
K9me2 Decrease H3.1/2 Increase Liver, kidney
K9me3 Decrease - - Kidney, brain
Binary PTMs K27me2K36me2 Increase H3.3 Stable abundance Liver, kidney, heart
K9me2K27me3 Decrease H3.1/2 Stable abundance Liver, heart
Combinatorial PTMs K9me2K36me3 Increase H3.3 (liver) - Liver, kidney, brain
K4me1K9me1K14ac-
K27me2K36me2
Increase H3.1/2 (heart, brain) - Liver, kidney, brain, heart
K23acK27me2K36me2 Increase H3.3 - Liver, Kidney
K23acR26me2K36me2 Increase H3.3 (brain) Increase (brain) Liver, kidney, heart
K14acK18acK27me2K36me2 Increase H3.3 - Liver, kidney, brain
R26me2K36me2 Increase H3.3 Stable/increase Liver, kidney, brain, heart
K27me3K36me1 Increase H3.3 Stable/increase Liver, kidney
K27me2K36me2 Increase H3.3 Stable/increase Liver, kidney, heart
K18acK23acK27me2K36me2 Increase H3.3 (kidney, brain) - Liver, heart
K9me1K14me1K27me2 Decrease H3.1/2 - Liver
ing that one PTMs in each pair might facilitate the for-
mation of the other one. This notion is in agreement
with a recent study, demonstrating that the loss of PRC2,
and subsequent loss of H3K27me3, reduces the amount
of H3K9me2 present on the inactive X chromosome (Xi)
(70). The relative abundances of several mutually exclu-
sive PTMs, such as H3K9me2 and H3K36me2, in contrast,
demonstrate strong negative correlation. Similar negative
correlation is observed between the two most abundant
binary PTMs H3K27me2K36me2 and H3K9me2K27me3.
We speculate these two binary PTMs might represent
PTM signatures of the two functionally distinct chromatin
states where H3K27me2K36me2 marks permissive chro-
matin and H3K9me2K27me3 marks inactive chromatin.
Interestingly, K27me2K36me2 is stably enriched on H3.3,
while K9me2K27me3 is enriched on H3.1/2 and H3 vari-
ant replacement with age is associated with a dynamic in-
crease in the K27me2K36me2 level and a decrease in the
K9me2K27me3 level in the chromatin (Table 2). In line with
the above, these results further support the notion that H3
variant replacement can be directly involved in modulating
the histone H3 modification landscape with age. In sum-
mary, our study provides the first comprehensive character-
ization of the dynamic changes in histone H3 PTM levels
during mouse lifespan and links these changes to the pro-
gressive age-dependent accumulation of the histone variant
H3.3.
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